Additionally, these dysregulated miRNAs should be further investigated using tissue samples and blood samples collected from multiple centers at various stages and subtypes, such as luminal A, luminal B, HER2, and basal breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.